Clinical trial · Interventional
Plantar Wart Treatment Using Adapalene Gel
NCT04823845CI-TRIAL-00065623withdrawnEarly Phase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Study never received IRB approval.
Summary
Brief summary (as posted)
This study seeks to research the efficacy of Adapalene 0.1% gel as a cost effective and low risk treatment option for plantar warts of the foot. Patients that present/diagnosed in designated clinics with plantar warts will be offered the option of being treated with regular superficial debridements of the epidermis and twice a day application of adapalene gel 0.1% under occlusion. Patients will be followed until resolution.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Plantar Wart | Verruca Plantaris | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Topical Adapalene Gel 0.1% | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Plantar Wart Treatment Using Adapalene Gel 0.1%
- description
- patients treated for plantar warts with Adapalene 0.1% gel
- interventionNames
- Drug: Topical Adapalene Gel 0.1%
Primary outcomes (1)
- measure
- Time Until Plantar Wart Resolution
- timeFrame
- 30-60 days
- description
- days
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 6 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * patients must be diagnosed with plantar warts Exclusion Criteria: * pregnant women * previous wart treatment within the last 2 weeks
References
Publications (3)
- BACKGROUNDGupta R, Gupta S. Topical adapalene in the treatment of plantar warts; randomized comparative open trial in comparison with cryo-therapy. Indian J Dermatol. 2015 Jan-Feb;60(1):102. doi: 10.4103/0019-5154.147835. PMID 25657417
- BACKGROUNDGupta R. Plantar warts treated with topical adapalene. Indian J Dermatol. 2011 Sep-Oct;56(5):513-4. doi: 10.4103/0019-5154.87135. PMID 22121266
- BACKGROUNDVlahovic TC, Khan MT. The Human Papillomavirus and Its Role in Plantar Warts: A Comprehensive Review of Diagnosis and Management. Clin Podiatr Med Surg. 2016 Jul;33(3):337-53. doi: 10.1016/j.cpm.2016.02.003. Epub 2016 Mar 29. PMID 27215155